p53-Adjusted Neoadjuvant Chemotherapy for potentially resectable Oesophageal Cancer "pANCHO".
Read time: 1 mins
Last updated:16th May 2007
The objective of this prospective randomized predictive marker study is to evaluate the interaction between a predictive marker and response to induction chemotherapy in patients with potentially resectable esophageal cancer. This study is designed to demonstrate the significant interaction of the two p53 genotypes (mutant versus normal) and response to 2 different neoadjuvant chemotherapies.
|Study start date||2007-05-16|